[go: up one dir, main page]

PL445246A1 - Mieszanina związków o działaniu stymulującym apetyt - Google Patents

Mieszanina związków o działaniu stymulującym apetyt

Info

Publication number
PL445246A1
PL445246A1 PL445246A PL44524623A PL445246A1 PL 445246 A1 PL445246 A1 PL 445246A1 PL 445246 A PL445246 A PL 445246A PL 44524623 A PL44524623 A PL 44524623A PL 445246 A1 PL445246 A1 PL 445246A1
Authority
PL
Poland
Prior art keywords
mixture
compounds
pure
appetite stimulating
stimulating effects
Prior art date
Application number
PL445246A
Other languages
English (en)
Inventor
Jacek Łyczko
Natalia Pachura
Marta Klemens
Michaela Godyla-Jabłoński
Kinga Adamenko
Antoni Szumny
Original Assignee
Uniwersytet Przyrodniczy we Wrocławiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Przyrodniczy we Wrocławiu filed Critical Uniwersytet Przyrodniczy we Wrocławiu
Priority to PL445246A priority Critical patent/PL445246A1/pl
Publication of PL445246A1 publication Critical patent/PL445246A1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Przedmiotem zgłoszenia jest mieszanina związków o działaniu stymulującym apetyt, charakteryzująca się tym, że w 100 ml zawiera 0,5 ml czystego kwasu nonanowego, 0,5 ml czystego 6-metylo-5-hepten-2-onu, 0,5 ml czystego heptan-2-onu i 1,5 ml spożywczego aromatu ananasowego. Mieszanina zawieszona jest w bezwonnym rozpuszczalniku o potwierdzonym statusie bezpieczeństwa i nietoksyczności.
PL445246A 2023-06-16 2023-06-16 Mieszanina związków o działaniu stymulującym apetyt PL445246A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL445246A PL445246A1 (pl) 2023-06-16 2023-06-16 Mieszanina związków o działaniu stymulującym apetyt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL445246A PL445246A1 (pl) 2023-06-16 2023-06-16 Mieszanina związków o działaniu stymulującym apetyt

Publications (1)

Publication Number Publication Date
PL445246A1 true PL445246A1 (pl) 2024-12-23

Family

ID=94644280

Family Applications (1)

Application Number Title Priority Date Filing Date
PL445246A PL445246A1 (pl) 2023-06-16 2023-06-16 Mieszanina związków o działaniu stymulującym apetyt

Country Status (1)

Country Link
PL (1) PL445246A1 (pl)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
K. OGAWA & M. ITO: "Biological and Pharmaceutical Bulletin, 2016, 39(9), 1559-1563", APPETITE-ENHANCING EFFECTS OF CURRY OIL. *
K. OGAWA & M. ITO: "Journal of Natural Medicines, 2019, 73, 513-522", APPETITE-ENHANCING EFFECTS OF NUTMEG OIL AND STRUCTURE–ACTIVITY RELATIONSHIP OF HABITUATION TO PHENYLPROPANOIDS. *
K. OGAWA ET AL.: "Journal of Natural Medicines, 2018, 72, 798-802", APPETITE-ENHANCING EFFECTS OF VANILLA FLAVOURS SUCH AS VANILLIN. *
K. OGAWA ET AL.: "Journal of Natural Medicines, 2020, 74, 710-721", APPETITE-ENHANCING EFFECTS OF INHALING CINNAMON, CLOVE, AND FENNEL ESSENTIAL OILS CONTAINING PHENYLPROPANOID ANALOGUES. *

Similar Documents

Publication Publication Date Title
Cerra Hypermetabolism-organ failure syndrome: A metabolic response to injury
NO20060185L (no) Anvendelse av isomalt (blanding av 1,6 GPS og 1,1 GPM) som prebiotikum blant annet for fremstilling av et legemiddel for behandling av tarmsykdommer
ES2165878T3 (es) Utilizacion del modafinil para el tratamiento de las apneas del sueño y trastornos de ventilacion de origen central.
ATE324110T1 (de) Stoffe mit serotoninartiger wirkung zur behandlung der schlafapnoe
KR960700054A (ko) 파킨슨씨 병 및 파킨슨 증후군의 치료에 리루졸의 이용(application of riluzole in the treatment of parkinson's disease and parkinsonian syndromes)
CY1116464T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
BRPI0509282A (pt) compostos contendo hidrazida inibidores de cftr e seus usos
CR7654A (es) Una combinacion de azelatina y esteroides
DE69332713D1 (de) Verwendung von Histamine-2 Agonisten zur Behandlung sexueller Funktionsstörungen
CO5700709A2 (es) Forma de administracion de ibuprofeno sodico
AR039633A2 (es) Uso de un compuesto tipo cabergolina para preparar un medicamento para el tratamiento de la fibromialgia y el sindrome de fatiga cronica
DE60234246D1 (de) Cannabinoiden zur behandlung von während des schlafens auftretenden atmungsstörungen
Bozzetti Nutritional issues in the care of the elderly patient
PL445246A1 (pl) Mieszanina związków o działaniu stymulującym apetyt
Mann Freud and the Future
Rinehart et al. Postoperative global amnesia reversed with flumazenil
Hellstrom et al. 874: Effects of Alpha-Blockers on Ejaculatory Function in Normal Subjects
PL445247A1 (pl) Mieszanina związków o działaniu redukującym apetyt
PL445251A1 (pl) Mieszanina związków o działaniu stymulującym apetyt
MX2023000899A (es) Administracion de beta-hidroxibutirato y compuestos relacionados en humanos para el tratamiento y/o prevencion de enfermedades respiratorias.
PL445252A1 (pl) Mieszanina związków o działaniu redukującym apetyt
ITRM20030485A1 (it) Composizione a base di citicolina in associazione con vitamine per la prevenzione ed il trattamento di patolgie oculari.
BRPI0514891A (pt) composição contendo derivados de prostaglandina e uso da referida composição
BRPI0413679A (pt) formulações de um inibidor seletivo da ciclooxigenase-2 e de um agente de modulação da serotonina para o tratamento da neoplasia
BR0316475A (pt) Combinação sinergìstica que compreende roflumilast e (r,r)-formoterol